Table 2.
Immune-related adverse events incidence by groups1, n (%)
|
IrAE by organ system n = 167
|
Grade < 2
|
Grade ≥ 2
|
| Dermatological | 43 (26) | 15 (9) |
| Colitis | 19 (11) | 10 (6) |
| Hepatitis | 40 (24) | 29 (17) |
| Endocrine | 18 (11) | 11 (7) |
| Polyarthritis | 3 (1) | 1 (0) |
| Pneumonitis | 10 (6) | 9 (5) |
| Constitutional | 52 (31) | 15 (9) |
| Other | 15 (9) | 22 (13) |
1
The incidence of immune-related adverse events (IrAEs) has been presented by patient groups categorized as those with IrAEs of grade < 2 and those with IrAEs of grade ≥ 2, stratified by the affected organ systems. IrAE: Immune-related adverse events.